Karen S. Marder, MD, MPH

Neurology: Aging and Dementia
Neurology
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Karen Marder, MD, MPH is the Sally Kerlin Professor of Neurology at Columbia University Irving Medical Center. She has served as the Chief of the Division of Aging and Dementia since 2001 and has directed the United Council for Neurologic Subspecialties (UCNS) fellowship in Behavioral Neurology and Neuropsychiatry since its inception.

In both research and patient care, Dr. Marder is focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, Dementia with Lewy bodies (DLB) and related disorders.

Her research has focused on characterizing the earliest motor and non-motor signs associated with genetic forms of PD. She served as co-chair and chair of the Executive Committee of the Parkinson Study Group (2006-2012), a consortium of North American investigators participating in collaborative PD research at 120 sites. She is the founding (1991) and current director of the multidisciplinary Huntington's Disease Society of America Center of Excellence at Columbia which serves over 250 families receiving clinical care and participating in clinical trials and observational studies. She serves as associate director of the Irving Institute for Clinical and Translational Research (CTSA). In addition, Dr. Marder is a principal investigator of the Columbia University–Weill Cornell NIH-funded NeuroNEXT site, a clinical trial network whose goal is to conduct Phase II biomarker informed neurological clinical trials.

Areas of Expertise / Conditions Treated

  • Alzheimer's Disease
  • Frontotemporal Dementia
  • Huntington's Disease (HD)
  • Lewy Body Disease
  • Memory Loss

Academic Appointments

  • Sally Kerlin Professor of Neurology (in the Gertrude H. Sergievsky Center, in the Taub Institute on Alzheimer's Disease and the Aging Brain, and in Psychiatry) at CUMC

Administrative Titles

  • Chief, Division of Aging and Dementia
  • Associate Director, Irving Institute for Clinical and Translational Research
  • Director, Clinical Research Resource, Irving Institute
  • Director, Huntington's Disease Center

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

710 West 168th Street
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • HMO
  • NYP Employee Plan
  • NY Signature
  • Student Health

Affinity Health Plan

  • Medicaid Managed Care

Amerigroup of New Jersey

  • New Jersey Services (Medicaid Managed Care)

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Cornell University Medical College, NY
  • Internship: St. Luke's-Roosevelt Hospital Center
  • Residency: Columbia University Medical Center
  • Fellowship: Columbia University Medical Center

Board Certifications

  • Neurology
America's Top Doctor
NY Top Doctor

Research

Dr. Marder's research has focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, and Alzheimer’s disease (AD) and related disorders. Most recently, my focus has been on characterizing the earliest signs associated with genetic forms of PD including Parkin, LRRK2, and GBA mutations, especially in individuals with early-onset PD.

In May 2006, I was elected to a 6-year term as co-chair of the Executive Committee of the Parkinson Study Group, a consortium of North American investigators participating in collaborative PD research at 120 sites.

I established the Huntington's Disease Society of America Center of Excellence at Columbia University in 1991, which I continue to lead today. We conduct a wide range of observational research and clinical trials for people with HD and those at risk.

I am particularly interested in the knowledge and attitudes of people at risk for genetic disorders. At Columbia, I also serve as associate director of the Irving Institute for Clinical and Translational Research (CTSA) where I direct the Clinical Research Resource for adult and pediatric inpatient and outpatient research. I am also the co-Principal Investigator for the Columbia/Weill-Cornell site of the NINDS-funded NeuroNEXT clinical trial network, whose mission is to conduct Phase 2 biomarker informed studies of neurological diseases.

Research Interests

  • Neuropsychiatry/Cognitive Disorders